Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041). (Q40366565)
Jump to navigation
Jump to search
scientific article published on 9 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041). |
scientific article published on 9 February 2010 |
Statements
1 reference
Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041). (English)
1 reference
Claudio Bordignon
1 reference
Hanneke W M van Laarhoven
1 reference
Walter Fiedler
1 reference
Ingrid M E Desar
1 reference
Jack J A van Asten
1 reference
Sandrine Marréaud
1 reference
Denis Lacombe
1 reference
Anne-Sophie Govaerts
1 reference
Jan Bogaerts
1 reference
Peter Lasch
1 reference
Johanna N H Timmer-Bonte
1 reference
Antonio Lambiase
1 reference
Cornelis J A Punt
1 reference
Arend Heerschap
1 reference
Carla M L van Herpen
1 reference
9 February 2010
1 reference
1 reference
16
1 reference
4
1 reference
1315-1323
1 reference
Identifiers
1 reference
1 reference